Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tracks Zanubrutinib's Real-World impact on rare blood cancer

NCT ID NCT05640102

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 31 times

Summary

This study is looking at how well the drug zanubrutinib works and how safe it is for people with Waldenström macroglobulinemia, a rare type of blood cancer. Researchers will track 111 participants from different racial and ethnic backgrounds, including those with specific genetic mutations. The goal is to better understand the drug's benefits and risks in these groups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for WALDENSTROM MACROGLOBULINEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • City of Hope National Medical Center

    RECRUITING

    Duarte, California, 91010-3012, United States

  • Clearview Cancer Institute

    RECRUITING

    Huntsville, Alabama, 35805-2606, United States

  • Comprehensive Cancer Centers of Nevada

    RECRUITING

    Las Vegas, Nevada, 89169-3321, United States

  • Eisenhower Medical Center, Lucy Curci Cancer Center

    RECRUITING

    Rancho Mirage, California, 92270-3221, United States

  • Hattiesburg Hematology and Oncology Clinic

    RECRUITING

    Hattiesburg, Mississippi, 39401-7233, United States

  • Los Angeles Cancer Network (Lacn)

    RECRUITING

    Glendale, California, 91204-3640, United States

  • Pan American Oncology Trials, Llc

    RECRUITING

    Rio Piedras, 00935, Puerto Rico

  • South Alabama Medical Science Foundation Mitchell Cancer Institute

    RECRUITING

    Mobile, Alabama, 36604-1405, United States

Conditions

Explore the condition pages connected to this study.